Cadre Holdings Inc Quick Ratio (CDRE) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cadre Holdings inc   (NYSE: CDRE)

Cadre Holdings Inc 's Quick Ratio

CDRE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.29 below Cadre Holdings Inc average.

Within Medical Equipment & Supplies industry 163 other companies have achieved higher Quick Ratio than Cadre Holdings Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2629 to 3090.

Explain Quick Ratio?
How much Cash & cash equivalents CDRE´s has?
What are CDRE´s Current Liabilities?




CDRE Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 266.17 % 13.15 % 111.22 % 113.99 % 6.77 %
Y / Y Cash & cash equivalent Change -60.73 % -69.07 % -1.63 % 62.25 % 29.81 %
Quick Ratio MRQ 0.29 0.68 1.18 1.42 2.68
CDRE's Total Ranking # 3090 # 2629 # 965 # 1014 # 814
Seq. Current Liabilities Change 208.66 % -41.79 % -1.46 % 106.83 % -4.62 %
Seq. Cash & cash equivalent Change 30.8 % -66.42 % -18.54 % 9.75 % 3.03 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 164
Healthcare Sector # 789
Overall Market # 3090


Quick Ratio Statistics
High Average Low
2.68 1.34 0.08
(Jun 30 2025)   (Dec 31 2020)




Financial Statements
Cadre Holdings Inc 's Current Liabilities $ 188 Millions Visit CDRE's Balance sheet
Cadre Holdings Inc 's Cash & cash equivalent $ 54 Millions Visit CDRE's Balance sheet
Source of CDRE's Sales Visit CDRE's Sales by Geography


Cumulative Cadre Holdings Inc 's Quick Ratio

CDRE's Quick Ratio for the trailling 12 Months

CDRE Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 124.99 % 60.67 % 60.44 % 35.97 % 4.75 %
Y / Y Cash & cash equivalent TTM Growth -24.51 % -1.04 % 32.56 % 46.32 % 39.64 %
Quick Ratio TTM 0.8 1.4 1.73 2.1 2.4
Total Ranking TTM # 4002 # 3978 # 2107 # 2453 # 1946
Seq. Current Liabilities TTM Growth 42.3 % 2.24 % 21.12 % 27.68 % 1.62 %
Seq. Cash & cash equivalent TTM Growth -18.45 % -16.92 % -0.37 % 11.84 % 6.9 %


On the trailing twelve months basis Due to in Current Liabilities in the Q2 2026 to $187.73 millions, cumulative Quick Ratio decreased to 0.8 below the Cadre Holdings Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Cadre Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3978 to 4002.

Explain Quick Ratio?
How much Cash & cash equivalents CDRE´s has?
What are CDRE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 900
Within the Market # 4002


trailing twelve months Quick Ratio Statistics
High Average Low
1.37 0.95 0.52
(Sep 30 2025)   (Mar 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Carlisle Companies Incorporated  0.75 $ 665.300  Millions$ 888.400  Millions
Northview Acquisition Corp  0.73 $ 12.200  Millions$ 16.622  Millions
Livanova Plc  0.73 $ 516.619  Millions$ 707.004  Millions
Angiodynamics Inc   0.72 $ 53.864  Millions$ 74.717  Millions
Rosecliff Acquisition Corp I  0.70 $ 14.000  Millions$ 19.869  Millions
Innovage Holding Corp   0.69 $ 141.326  Millions$ 203.891  Millions
Msa Safety Inc  0.69 $ 200.057  Millions$ 288.899  Millions
Valion Bio Inc   0.69 $ 2.108  Millions$ 3.046  Millions
Lensar Inc   0.69 $ 13.565  Millions$ 19.640  Millions
West Pharmaceutical Services Inc   0.68 $ 435.800  Millions$ 640.500  Millions
Nexalin Technology Inc   0.68 $ 1.005  Millions$ 1.485  Millions
Orthofix Medical Inc   0.66 $ 103.810  Millions$ 157.010  Millions
Privia Health Group Inc   0.65 $ 412.200  Millions$ 634.444  Millions
Positron Corporation  0.60 $ 1.357  Millions$ 2.252  Millions
Baxter International Inc   0.60 $ 2,151.000  Millions$ 3,591.000  Millions
Edap Tms Sa  0.58 $ 21.542  Millions$ 36.849  Millions
Invo Fertility Inc   0.57 $ 3.733  Millions$ 6.520  Millions
Align Technology inc   0.55 $ 1,102.591  Millions$ 1,999.055  Millions
Interpace Biosciences Inc   0.54 $ 2.688  Millions$ 4.951  Millions
FAMILY OFFICE OF AMERICA, INC.  0.53 $ 0.637  Millions$ 1.208  Millions
Stryker Corp  0.52 $ 3,507.000  Millions$ 6,684.000  Millions
Embecta Corp   0.51 $ 214.700  Millions$ 419.800  Millions
Milestone Scientific Inc   0.51 $ 2.067  Millions$ 4.043  Millions
Strata Critical Medical Inc   0.50 $ 23.017  Millions$ 45.779  Millions
Alphatec Holdings Inc   0.50 $ 118.662  Millions$ 237.966  Millions
Teleflex Incorporated  0.45 $ 326.602  Millions$ 720.379  Millions
Novocure Limited  0.45 $ 99.287  Millions$ 220.710  Millions
Ss Innovations International Inc  0.43 $ 13.647  Millions$ 31.892  Millions
Stereotaxis Inc   0.42 $ 11.218  Millions$ 26.797  Millions
Glucotrack Inc   0.38 $ 1.124  Millions$ 2.988  Millions

Date modified: 2026-09-11T10:05:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.